<?xml version='1.0' encoding='utf-8'?>

<rss version="2.0">
  <channel>
    <title>The Federal Register</title>
    <link>http://thefederalregister.com/b.p/agency/Food_and_Drug_Administration/2006-12-15/</link>
    <description>Daily Publications of Meetings and Rules Changes for the Federal Government</description>
    <pubDate>Sun, Nov 23 2008 11:00:00 GMT</pubDate>
    <lastBuildDate>Sun, Nov 23 2008 11:00:00 GMT</lastBuildDate>
    <webMaster>info@thefederalregister.com</webMaster>
    <item>
  <title><![CDATA[  Agency Information Collection Activities; Submission for Office  of Management and Budget Review; Comment Request;]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-15-E6-21317</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-15-E6-21317</guid>
  <pubDate>Fri, Dec 15 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Agency Information Collection Activities; Submission for Office  of Management and Budget Review; Comment Request;]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-15-E6-21375</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-15-E6-21375</guid>
  <pubDate>Fri, Dec 15 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  Drug Products Containing Quinine; Enforcement Action Dates]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-15-06-9713</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) is announcing its 
intention to take enforcement action against unapproved drug products 
containing quinine (including quinine sulfate and any other salt of 
quinine) and persons who cause the manufacture of such products or 
their shipment in interstate commerce. Drug products containing 
quinine, quinine sulfate, and any other salt of quinine are new drugs 
that require approved applications. One firm has an approved 
application to market a drug product containing quinine sulfate to 
treat malaria; this product has been designated an orphan drug product. 
Other manufacturers who wish to market a drug product containing 
quinine, quinine sulfate, or any other salt of quinine must obtain FDA 
approval of a new drug application (NDA) or an abbreviated new drug 
application (ANDA); consideration of any such applications will be 
subject to the rights of the current NDA holder under the Orphan Drug 
Act.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-15-06-9713</guid>
  <pubDate>Fri, Dec 15 2006 11:00:00 GMT</pubDate>
</item>
<item>
  <title><![CDATA[  International Drug Scheduling; Convention on Psychotropic  Substances; Single Convention on Narcotic Drugs; World]]></title>
  <link>http://thefederalregister.com/d.p/2006-12-15-E6-21318</link>
  <description><![CDATA[ The Food and Drug Administration (FDA) is providing interested 
persons with the opportunity to submit written comments concerning 
recommendations by the World Health Organization (WHO) to impose 
international manufacturing and distributing restrictions, under 
international treaties, on certain drug substances. The comments 
received in response to this notice will be considered in preparing the 
U.S. position on these proposals for a meeting of the United Nations 
Commission on Narcotic Drugs (CND) in Vienna, Austria, March 12 to 16, 
2007. This notice is issued under the Controlled Substances Act.
<script type="text/javascript">
<!--
google_ad_client = "pub-2051746026283201";
google_ad_width = 728;
google_ad_height = 15;
google_ad_format = "728x15_0ads_al";
//2007-08-22: federalregister-rss
google_ad_channel = "2005962856";
google_color_border = "CC0000";
google_color_bg = "FFFFFF";
google_color_link = "CC0000";
google_color_text = "000000";
google_color_url = "008000";
//-->
</script>
<script type="text/javascript"
  src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script>
]]></description>
  <guid>http://thefederalregister.com/d.p/2006-12-15-E6-21318</guid>
  <pubDate>Fri, Dec 15 2006 11:00:00 GMT</pubDate>
</item>
</channel>
</rss>

